Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|June 29, 2022
Objective and subjective evaluation of Velopharyngeal Dysfunction (VPD) following surgical repair of the cleft palate using the furlow palatoplasty - A new toolM I Rizzo, N Fallico, N Beneduce, et al.
BMC Veterinary Research|September 7, 2014
Evaluation of the effects of methadone and tramadol on postoperative analgesia and serum interleukin-6 in dogs undergoing orthopaedic surgeryLarissa B Cardozo, Lourenço C Cotes, Marcia A P Kahvegian, et al.
Clinical Pharmacology and Therapeutics|November 14, 2019
A Machine-Learning Approach to Identify a Prognostic Cytokine Signature That Is Associated With Nivolumab Clearance in Patients With Advanced MelanomaRui Wang, Xiao Shao, Junying Zheng, et al.
Scientific Reports|July 17, 2021
Engineered mucoperiosteal scaffold for cleft palate regeneration towards the non-immunogenic transplantationM I Rizzo, L Tomao, S Tedesco, et al.
ESMO Open|February 8, 2021
A matching-adjusted indirect comparison of combination nivolumab plus ipilimumab with BRAF plus MEK inhibitors for the treatment of BRAF-mutant advanced melanoma☆A A Tarhini, K Toor, K Chan, et al.
Cancer Immunology Research|August 14, 2021
TMB and Inflammatory Gene Expression Associated with Clinical Outcomes following Immunotherapy in Advanced MelanomaF Stephen Hodi, Jedd D Wolchok, Dirk Schadendorf, et al.
Neuro-Oncology|April 21, 2021
Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204)Hussein A Tawbi, Peter A Forsyth, F Stephen Hodi, et al.
The New England Journal of Medicine|September 29, 2019
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced MelanomaJames Larkin, Vanna Chiarion-Sileni, Rene Gonzalez, et al.
Pageof 5